Metraipolis › archive › dc_217eaf465017

Neutrophil-based delivery platforms: from natural mechanisms to engineered therapeutics — Europe PMC PMID:41328335

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41328335
DOI
10.7150/thno.117363
License (as archived)
solo-consultazione
Archived
2026-11-07T05:14:26.008Z
SHA-256 of the archived text
23766735cd66a41027a43b79b805e8216ad55bff880f0ee8ac1e391817fbed31
Stable URL of this page
https://metraipolis.com/documento/dc_217eaf465017

How to cite

Neutrophil-based delivery platforms: from natural mechanisms to engineered therapeutics — Europe PMC PMID:41328335 — Europe PMC (en), https://europepmc.org/article/MED/41328335 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_217eaf465017 (Metraipolis archive dc_217eaf465017, sha256 23766735cd66a41027a43b79b805e8216ad55bff880f0ee8ac1e391817fbed31)
BibTeX
@misc{dc217eaf465017,
  title = {Neutrophil-based delivery platforms: from natural mechanisms to engineered therapeutics — Europe PMC PMID:41328335},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41328335},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_217eaf465017; sha256 23766735cd66a41027a43b79b805e8216ad55bff880f0ee8ac1e391817fbed31},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41328335. Agents can read the archived copy with the MCP tool read_document.